Sign in
TerminatedNo phase

An Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure

Key facts

Who runs it
Paragate Medical LTD
Where
Georgia, Israel, and Poland3 sites in 3 countriesChoose a country to see its sites
Trial code
Status
Terminated
People taking part
3 people enrolled
Started
24 Feb 2022
Ended
17 Jan 2024
Type of study
Interventional
Treatments tested
  • automated continual water removal system
Record updated
19 January 2024
Why it stopped
challenges in recruitment

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • ≥ 21 years of age; Life expectancy > 6 months; HF, NYHA class II-IV; > 1 HF related admissions in the last 12 months; Fluid congestion (2 signs of pitting oedema, jugular distention, BW elevation, nocturnal dyspnoea score, respiration rate, pulmonary congestion and/or pleural effusion per chest x-ray, ascites); Failure to achieve effective diuresis and congestion relief despite appropriate or escalating diuretic doses or combination of diuretics (eg. Furosemide and Metolazone); Eligible for general anaesthesia and laparoscopic procedure; Able to give written informed consent; Ability to comply with study procedures and ability to operate the device; Women of childbearing potential should use adequate contraception for as long as the device is implanted

Who cannot take part

  • • Any non-cardiac disease with life expectancy < 1 year; Any patient listed for solid organ transplantation; Patients with history, or with indication for, mechanical circulatory support; iv inotropes required in last 3 months (INTERMACS Score ≤3); Immunocompromised (e.g. chronic steroid treatment, HIV, etc.); Insulin dependent diabetes; Severe hyponatraemia as defined by a serum Sodium < 120 mmol/l; Serum Albumin < 2.5 g/dL; eGFR < 25 ml/min/1.73m2 by MDRD method; Previous significant intraabdominal surgery, severe abdominal adhesions, intra-abdominal foreign body (except for small inguinal mesh); Large diaphragmatic hernia, or surgically irreparable, complex or recurring hernia; 6 minutes' walk test of less than 100 meter; History (>6 months) of diaphragmatic hernia, inflammatory or ischemic bowel disease and frequent episodes of diverticulitis; Gastrointestinal haemorrhage within the last 4 months; Bacterial peritonitis episode within the last 24 months; > 2 systemic or local infections, such as urinary tract infection or abdominal skin infection within the last 6 months; Liver cirrhosis; BMI > 40 presenting a risk for surgery; Patients with contraindications for general anaesthesia or laparoscopic surgery; Unsuitability for self-maintenance of the experimental home set-up; Presence of any current cancer; Presence of any active implantable or body-worn devices that cannot be removed excluding ICD / pacemaker; Pregnancy; Patients being in another therapeutic clinical study

This trial has no sites in United States.

It has sites in 3 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will assess the functionality and tolerability of an automated continual water removal system in up to 8 patients with HF and diuretic resistance.

Read full original descriptionShow less

intervention: Implanted absorption chamber, connected to an external pump. Follow up: 3 months post activation.

The group in the trial

  • Implanted deviceTreatment being tested

    Implantation and activation of an automated continual water removal system, including 4-months follow up

    Treatment: automated continual water removal system

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Multi-centre, Prospective, Open Label, Uncontrolled Pilot Study to Assess the Feasibility and Tolerability of an Automated Continual Water Removal System in Patients With Advanced Diuretic Resistant Heart Failure
Record updated
19 January 2024